Norfloxacin Therapy for Patients With Cirrhosis and Severe Liver Failure

NCT01037959 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

291

Enrollment

OTHER

Sponsor class

Stopped lack of recruitement

Conditions

Cirrhosis

Interventions

DRUG: Norfloxacin
DRUG: Placebo

Sponsor

Assistance Publique - Hôpitaux de Paris